Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia

Canadian Journal of Anesthesia

Volumn 49, Issue 4, 2002, Pages 353-360

  Dragne, Alexandrina ^a   Varin, France ^a   Plaud, Benoît ^b   Donati, François ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIGITALIS; DIURETIC AGENT; DRUG METABOLITE; FENTANYL; ISOFLURANE; NITROUS OXIDE; OXYGEN; PROPOFOL; ROCURONIUM; THIOPENTAL;

ADULT; AGED; ANESTHESIA INDUCTION; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG POTENTIATION; ENDOTRACHEAL INTUBATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MUSCLE RELAXATION; MUSCLE TONE; MUSCLE TWITCH; MYOGRAPHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYNAPSE; PHARMACODYNAMICS; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0036113755     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03017322     Document Type: Article

References (21)

1. Clinical pharmacology of rocuronium (Org 9426); study of the time course of action, dose requirement, reversibility and pharmacokinetics
2. Continuous infusion of vecuronium: The effect of anesthetic agents
3. Pharmacokinetic-pharmacodynamic modeling of doxacurium: Effect of input rate
4. Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium
5. Kinetics of desflurane, isoflurane, and halothane in humans
6. Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters
7. High-performance liquid chromatography-electrochemical detection of vecuronium and its metabolites in human plasma
8. Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models
9. Pharmacokinetics and pharmacodynamics of a second dose of atracurium in anaesthetised patients
10. Pharmacokinetics of rocuronium bromide in patients with and without renal failure
11. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation
12. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease
13. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: A preliminary report
14. Stimulus frequency and dose-response curve to d-tubocurarine in man
15. Estimation of the potency of ORG 9426 using two different modes of nerve stimulation
16. Dose-response relationship and time course of action of Org 9426. A new muscle relaxant of intermediate duration evaluated under various anaesthetic techniques
17. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia
18. Muscle paralysis by rocuronium during halothane, enflurane, isoflurane, and total intravenous anesthesia
19. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis
20. Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans
21. Dose-response and concentration-response relation of rocuronium infusion during propofol-nitrous oxide and isoflurane-nitrous oxide anaesthesia